This Pill May Help Pancreatic Cancer Patients Live Longer

Pancreatic cancer has long been one of the worst diagnoses a person could get. A new drug from Revolution Medicines may offer some hope. In clinical trial results announced Monday, patients with metastatic cancer who took the company’s targeted pill lived nearly twice as long as patients who received chemotherapy, or a median of 13.2 months versus 6.7 months.